View on Pubmed.gov 19010685 | View on doi.org 10.1016/j.bmc.2...
Engineered production of iso-migrastatin in heterologous Streptomyces hosts.
- Division of Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, WI 53705, USA.
Abstract
Glutarimide-containing polyketides such as migrastatin (MGS) are well known for their ability to inhibit tumor cell migration. We have previously shown that MGS is derived from iso-migrastatin (iso-MGS) via a H(2)O-mediated ring-expansion rearrangement. A bacterial artificial chromosome (BAC) library of Streptomyces platensis NRRL18993, an iso-MGS producer, was constructed. From this library, pBS11001, a BAC clone harboring the intact iso-MGS biosynthetic gene cluster, was identified. Mobilization of pBS11001 into five heterologous Streptomyces hosts afforded recombinant strains, SB11001, SB11002, SB11003, SB11004, and SB11005, respectively. Under a standard set of media and fermentation conditions, the recombinant strains all produced the same profile of iso-MGS as that of S. platensis NRRL18993. These findings highlight the strength and flexibility of the BAC-based technology for natural product production and engineering in heterologous Streptomyces model hosts.
References
Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8794-7
Expert Opin Drug Discov. 2006 Oct;1(5):409-37
ACS Chem Biol. 2007 Mar 20;2(3):159-62
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1541-6
Cited by 56 citations (total)
Journal Article Review
host for refactoring of diverse bioactive secondary metabolites.
Electronic publication date July 6, 2021
Vivek Sharma [...] Richa Salwan et al.
Microbial secondary metabolites are intensively explored due to their demands in pharmaceutical, agricultural and food industries. are one of...
Journal Article Review
Focused Review: Cytotoxic and Antioxidant Potentials of Mangrove-Derived .
Electronic publication date November 23, 2017
Hooi-Leng Ser [...] Learn-Han Lee et al.
Human life expectancy is rapidly increasing with an associated increasing burden of chronic diseases, such as neurodegenerative diseases and cancer....
Conflict of interest statement
MeSH
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
Substances
- •
- •
- •